Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice

Molecular Genetics and Metabolism

Volumn 96, Issue 4, 2009, Pages 239-244

  Xiao, Ning ^a   Yin, Miao ^a   Zhang, Liang ^a   Qu, Xuebin ^a   Du, Hui ^a   Sun, Xiaoming ^a   Mao, Liufeng ^a   Ren, Guocheng ^a   Zhang, Cong ^a   Geng, Yue ^a   An, Liguo ^a   Pan, Jie ^a  

^a SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

apoE; Atherosclerosis; Inflammatory factors; NF B; TNF

Indexed keywords

APOLIPOPROTEIN E; BETA ACTIN; CHOLESTEROL; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; I KAPPA B ALPHA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD LEVEL; DISEASE COURSE; DOWN REGULATION; INFLAMMATION; INTIMA; LIPID ANALYSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; GENOTYPE; INFLAMMATION MEDIATORS; LIPIDS; LIVER; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 61849085269     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.11.166     Document Type: Article

References (26)

1. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
2. Getz G.S. Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J. Lipid Res. 46 (2005) 1-10
3. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
4. de Winther M.P., Kanters E., Kraal G., and Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 904-914
5. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., and Forrester J.S. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65 (1990) 297-302
6. Rus H.G., Niculescu F., and Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89 (1991) 247-254
7. Canault M., Peiretti F., Mueller C., Kopp F., Morange P., Rihs S., Portugal H., Juhan-Vague I., and Nalbone G. Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis 172 (2004) 211-218
8. Ohta H., Wada H., Niwa T., Kirii H., Iwamoto N., Fujii H., Saito K., Sekikawa K., and Seishima M. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180 (2005) 11-17
9. Branen L., Hovgaard L., Nitulescu M., Bengtsson E., Nilsson J., and Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2137-2142
10. Schreyer S.A., Vick C.M., and LeBoeuf R.C. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J. Biol. Chem. 277 (2002) 12364-12368
11. Schreyer S.A., Peschon J.J., and LeBoeuf R.C. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J. Biol. Chem. 271 (1996) 26174-26178
12. Ye H.Y., Yin M., Shang Y.J., Dai X.D., Zhang S.Q., Jing W., Du H.Q., Zhang L., and Pan J. Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice. Sheng Li Xue Bao 60 (2008) 51-58
13. Boesten L.S., Zadelaar A.S., van Nieuwkoop A., Gijbels M.J., de Winther M.P., Havekes L.M., and van Vlijmen B.J. Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice. Cardiovasc. Res. 66 (2005) 179-185
14. Canault M., Peiretti F., Poggi M., Mueller C., Kopp F., Bonardo B., Bastelica D., Nicolay A., Alessi M.C., and Nalbone G. Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha. J. Pathol. 214 (2008) 574-583
15. Popa C., Netea M.G., van Riel P.L., van der Meer J.W., and Stalenhoef A.F. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res. 48 (2007) 751-762
16. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., and Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107 (2001) 1255-1262
17. Iiyama K., Hajra L., Iiyama M., Li H., DiChiara M., Medoff B.D., and Cybulsky M.I. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85 (1999) 199-207
18. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., Asano M., Moriwaki H., and Seishima M. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 656-660
19. -/- mice. J. Interferon Cytokine Res. 22 (2002) 661-670
20. Elhage R., Clamens S., Besnard S., Mallat Z., Tedgui A., Arnal J., Maret A., and Bayard F. Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 156 (2001) 315-320
21. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., and Achong M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101 (1998) 311-320
22. Davenport P., and Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163 (2003) 1117-1125
23. Secchiero P., Candido R., Corallini F., Zacchigna S., Toffoli B., Rimondi E., Fabris B., Giacca M., and Zauli G. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 114 (2006) 1522-1530
24. Zauli G., and Secchiero P. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev. 17 (2006) 245-257
25. Feingold K.R., Soued M., Adi S., Staprans I., Neese R., Shigenaga J., Doerrler W., Moser A., Dinarello C.A., and Grunfeld C. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. Arterioscler. Thromb. 11 (1991) 495-500
26. Memon R.A., Grunfeld C., Moser A.H., and Feingold K.R. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132 (1993) 2246-2253